These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 37222479)

  • 21. Ophthalmic nano-bioconjugates: critical challenges and technological advances.
    Sanap SN; Bisen AC; Agrawal S; Kedar A; Bhatta RS
    Ther Deliv; 2023 Jul; 14(7):419-441. PubMed ID: 37535389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifunctional Nanocomposites Based on Liposomes and Layered Double Hydroxides Conjugated with Glycylsarcosine for Efficient Topical Drug Delivery to the Posterior Segment of the Eye.
    Gu Y; Xu C; Wang Y; Zhou X; Fang L; Cao F
    Mol Pharm; 2019 Jul; 16(7):2845-2857. PubMed ID: 31244219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye.
    Wang Y; Xu X; Gu Y; Cheng Y; Cao F
    Expert Opin Drug Deliv; 2018 Jul; 15(7):687-701. PubMed ID: 29985660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraocular delivery considerations of ocular biologic products and key preclinical determinations.
    Hughes P; Rivers HM; Bantseev V; Yen CW; Mahler HC; Gupta S
    Expert Opin Drug Deliv; 2023 Feb; 20(2):223-240. PubMed ID: 36632784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
    Del Amo EM; Urtti A
    Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Periocular routes for retinal drug delivery.
    Raghava S; Hammond M; Kompella UB
    Expert Opin Drug Deliv; 2004 Nov; 1(1):99-114. PubMed ID: 16296723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of Recent Advances in Nano-Based Ocular Drug Delivery.
    Liu LC; Chen YH; Lu DW
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges and opportunities for drug delivery to the posterior of the eye.
    Cabrera FJ; Wang DC; Reddy K; Acharya G; Shin CS
    Drug Discov Today; 2019 Aug; 24(8):1679-1684. PubMed ID: 31175955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aqueous eye drops containing drug/cyclodextrin nanoparticles deliver therapeutic drug concentrations to both anterior and posterior segment.
    Loftsson T; Stefánsson E
    Acta Ophthalmol; 2022 Feb; 100(1):7-25. PubMed ID: 33876553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contact lenses: promising devices for ocular drug delivery.
    Guzman-Aranguez A; Colligris B; Pintor J
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy.
    Swetledge S; Jung JP; Carter R; Sabliov C
    J Nanobiotechnology; 2021 Jan; 19(1):10. PubMed ID: 33413421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
    Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
    Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New ophthalmic drug delivery systems.
    Castro-Balado A; Mondelo-García C; Zarra-Ferro I; Fernández-Ferreiro A
    Farm Hosp; 2020 Jul; 44(4):149-157. PubMed ID: 32646346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microrobots: a new era in ocular drug delivery.
    Fusco S; Ullrich F; Pokki J; Chatzipirpiridis G; Özkale B; Sivaraman KM; Ergeneman O; Pané S; Nelson BJ
    Expert Opin Drug Deliv; 2014 Nov; 11(11):1815-26. PubMed ID: 25001411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems.
    Wu KY; Joly-Chevrier M; Akbar D; Tran SD
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted Nanotherapies for the Posterior Segment of the Eye: An Integrative Review on Recent Advancements and Challenges.
    Gogoi NR; Marbaniang D; Pal P; Ray S; Mazumder B
    Pharm Nanotechnol; 2022 Nov; 10(4):268-278. PubMed ID: 35946098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Ocular Drug Delivery Systems: An Update on Microemulsions.
    Üstündağ Okur N; Çağlar EŞ; Siafaka PI
    J Ocul Pharmacol Ther; 2020; 36(6):342-354. PubMed ID: 32255728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel strategies for anterior segment ocular drug delivery.
    Cholkar K; Patel SP; Vadlapudi AD; Mitra AK
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):106-23. PubMed ID: 23215539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multifunctional carboxymethyl chitosan derivatives-layered double hydroxide hybrid nanocomposites for efficient drug delivery to the posterior segment of the eye.
    Wang Y; Zhou L; Fang L; Cao F
    Acta Biomater; 2020 Mar; 104():104-114. PubMed ID: 31931169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.